Vaccines for health care workers

Vaccines

Volumn , Issue , 2008, Pages 1453-1477

  Weber, David J ^a   Rutala, William A ^b,c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952135322     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50070-2     Document Type: Chapter

References (563)

1. WB Patterson, DE Craven, DA Schwartz, et al. (1985) Occupational hazards to hospital personnel. Ann Intern Med 102 658-680.
2. JJ Gestal (1987) Occupational hazards in hospitals: risk of infection. Br J Ind Med 44 435-442.
3. RM Moore and RG Kaczmarek (1991) Occupational hazards to healthcare workers: diverse, ill-defined and not fully appreciated. Am J Infect Control 18 316-327.
4. KK Hoffmann, DJ Weber and WA Rutala (1991) Infection control strategies relevant to employee health. AAOHN J 39 167-181.
5. DJ Diekema and BN Doebbeling (1995) Employee health and infection control. Infect Control Hosp Epidemiol 16 292-301.
6. LH Clever and Y LeGuyader (1995) Infectious risks for healthcare workers. Annu Rev Public Health 16 141-164.
7. KA Sepkowitz (1996) Occupationally acquired infections in healthcare workers: Part I. Ann Intern Med 125 826-834.
8. KA Sepkowitz (1996) Occupationally acquired infections in healthcare workers: Part II. Ann Intern Med 125 917-928.
9. B Rogers (1997) Health hazards in nursing and healthcare: an overview. Am J Infect Control 25 248-261.
10. EA Bolyard, OC Tablan, WW Williams, et al. (1998) Guidelines for infection control in health care personnel. Am J Infect Control 26 289-354.
11. CY Chong, DA Goldman and WC Huskins (1998) Prevention of occupationally acquired infections among health-care workers. Pediatr Rev 19 219-231.
12. OC Tablan, EA Bolyard, CN Shapiro and WW Williams (1998) Personnel health service. JV Bennett, PS Brachman (Eds) Hospital Infections 4th edn Boston: Little, Brown 23-52.
13. RJ Sharbaugh (1999) The risk of occupational exposure and infection with infectious disease. Nursing Clin North Am 34 493-508.
14. ML Bertin (1999) Communicable diseases: infection, prevention for nurses at work and home. Nursing Clin North Am 34 509-526.
15. IG Udasin (2000) Health care workers. Primary Care 27 1079-1101.
16. S Sebazco (2002) Occupational health. In APIC Text of Infection Control and Epidemiology Washington, DC: Association for Professionals in Infection Control and Epidemiology 79-81. 79–2
17. P Falk (2004) Infection control and the employee health service. CG Mayhall (Eds) Hospital Epidemiology and Infection Control 3rd edn Philadelphia: Lippincott Williams & Wilkins 1765-1772.
18. KA Sepkowitz and L Eisenberg (2005) Occupational deaths among healthcare workers. Emer Infect Dis 11 1003-1008.
19. EL Larson (1995) APIC guideline for handwashing and hand antisepsis in healthcare settings. Am J Infect Control 23 251-269.
20. JM Boyce and D Pittet (2002) Guideline for hand hygiene in health-care settings. Am J Infect Control 30 1-46.
21. A Trampuz and AF Widmer (2004) Hand hygiene: a frequent missed lifesaving opportunity during patient care. Mayo Clin Proc 79 109-116.
22. PA Jumaa (2005) Hand hygiene: simple and complex. Int J Infect Dis 9 3-14.
23. A Akyol, H Ulusoy and I Ozen (2006) Handwashing: a simple, economical and effective method for preventing nosocomial infections in intensive care units. J Hosp Infect 62 395-405.
24. JS Gardner (1996) For the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 17 53-80.
25. DJ Weber and WA Rutala (2001) Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis 32 446-456.
26. Rebmann T. Management of patients infected with airborne-spread diseases: an algorithm for infection control professionals. Am J Infect Control 33:571–579.
27. WJ Buesching, JC Neff and HM Sharma (1989) Infectious hazards in the clinical laboratory: a program to protect laboratory personnel. Clin Lab Med 9 351-361.
28. DL Sewell (1995) Laboratory-associated infections and biosafety. Clin Microbiol Rev 8 389-405.
29. WL Turnberg (1996) Biohazardous Waste: Risk Assessment, Policy, and Management New York: John Wiley & Sons
30. Biosafety in Microbiological and Biomedical Laboratories (HHS Publ No 017-040-00547-4) Rockville, MD: Department of Health and Human Resources
31. DO Fleming and DL Hunt (2000) Biological Safety: Principles and Practices 3rd edn. Washington, DC: ASM Press
32. JM Rusnak, MG Kortepeter, RJ Hawley, AO Anderson, E Boudreau and E Eitzen (2004) Risk of occupational acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2 281-293.
33. Clinical Laboratory Standards Institute (2004) Clinical Laboratory Safety: Approved Guideline-Second Edition (NCCLS Document GP17-A2) Wayne, PA: National Committee for Clinical Laboratory Standards
34. Occupational Safety and Health Administration (2001) Occupational exposure to bloodborne pathogens; needlestick, and other sharps injuries; final rule. Fed Reg 66 5318-5325.
35. Occupational Safety and Health Administration Tuberculosis OSHA standards. www.osha.gov/SLTC/tuberculosis.standard.html Accessed June 1, 2006
36. Immunization of health-care workers recommendations of the Advisory Committee on Immunization Practices. (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC) 46(RR-18), 1-42.
37. General recommendations on immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMR 55(RR-15), 1-48.
38. Advisory Committee on Immunization Practices Recommended adult immunization schedule, by vaccine and age group, United States, October 2005—September 2006. www.cdc.gov/vaccines/recs/schedules/default.htm Accessed 10/29/2007
39. ACP Task Force on Adult Immunization and Infectious Disease Society of America (1994) Guide for Adult Immunization 3rd edn. Philadelphia: American College of Physicians
40. American Academy of Pediatrics (2006) Red Book: Report of the Committee on Infectious Diseases 27th edn. Elk Grove Village, IL: American Academy of Pediatrics
41. GA Poland and DJ Haiduven (2002) Immunization in the health-care worker. APIC Text of Infection Control and Epidemiology Washington, DC: Association for Professionals in Infection Control and Epidemiology 80.1-80.32.
42. MG DeCastro, GA Denys, LL Fauerbach, et al. (1999) APIC position paper: immunization. Am J Infect Control 27 52-53.
43. DJ Weber and WA Rutala (1997) Selection and use of vaccines for healthcare workers. Infect Control Hosp Epidemiol 18 682-687.
44. ER Kessler (1997) Vaccine-preventable diseases in health care. Occup Med 12 731-739.
45. Poland GA, Schaffner W, Publiese G (eds). Immunizing Healthcare Workers: A Practical Approach. Thorofare, NJ, Slack, 2000.
46. RK Zimmermann and JA Ball (2001) Adult vaccinations. Prim Care Clin Office Pract 25 763-790.
47. JJ Nora and BN Doebbeling (2003) New vaccines and vaccination programs for hospital staff members. Wenzel (Eds) Prevention and Control of Nosocomial Infections 4th edn Philadelphia: Lippincott Williams & Wilkins 413-429.
48. MD Decker, DJ Weber and WA Schaffner (2004) Vaccination of healthcare workers. CG Mayhall (Eds) Hospital Epidemiology and Infection Control 3rd edn Philadelphia: Lippincott Williams & Wilkins 1381-1399.
49. RK Zimmerman and DB Middleton (2005) Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005. J Fam Prac 54(Suppl 1), S27-S36.
50. Centers for Disease Control and Prevention (2006) Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR 55 629-630.
51. Preventing tetanus diphtheria, and pertussis among adolescents use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55(RR-3), 1-43.
52. Advisory Committee on Immunization Practices ACIP votes to recommend use of combined tetanus, diphtheria and pertussis (Tdap) vaccine for adults. www.cdc.gov/nip/tdap/tdap_adult_rec.pdf Accessed June 1, 2006
53. MA van den Hoven and MF Verweij (2003) Should we promote influenza vaccination of health care workers in nursing homes? Some ethical arguments in favour of immunization. Age and Ageing 32 487-489.
54. GA Poland, P Tosh and RM Jocobson (2005) Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 23 2251-2255.
55. CJ Hoffmann and TM Perl (2005) The next battleground for patient safety: influenza, immunization of healthcare workers. Infect Control Hosp Epidemiol 26 850-851.
56. TR Talbot, SF Bradley, SE Cosgrove, C Ruef, JD Siegel and DJ Weber (2005) Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortage. Infect Control Hosp Epidemiol 26 882-890.
57. Centers for Disease Control and Prevention (2006) Influenza vaccination of health-care personnel. MMWR 55(RR-2), 1-15.
58. Measles, mumps and rubella-vaccine use and strategies for the elimination of measles, rubella and congenital rubella syndrome recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47(RR-8), 1-57.
59. Control and prevention of rubella evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 50(RR-12), 1-23.
60. DJ Weber, WA Rutala and H Hamilton (1996) Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol 17 694-705.
61. Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45(RR-11), 1-36.
62. Prevention of varicella updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-6), 1-5.
63. Centers for Disease Control and Prevention Prevention of varicella—provisional updated ACIP recommendations for varicella vaccine use. www.cdc.gov/nip/vaccine/varicella/varicella_acip_recs.pdf Accessed June 1, 2006
64. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 54(RR-16), 1-39.
65. U.S. Updated Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 50(RR-11), 1-67.
66. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55(Early Release), 1-63.
67. Prevention of pneumococcal disease recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-8), 1-24.
68. Poliomyelitis prevention in the United States introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-3), 1-25.
69. Control and prevention of meningococcal disease recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 54(RR-7), 1-21.
70. Control and prevention of serogroup C meningococcal disease evaluation and management of suspected outbreaks. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-5), 13-21.
71. The role of BCG vaccine in the prevention and control of tuberculosis in the United States a joint statement by the Advisory Committee for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 45(RR-4), 1-18.
72. Human rabies prevention-United States, 1999: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 48(RR-1), 1-21.
73. Typhoid immunization recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 43(RR-14), 1-7.
74. Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 50(RR-10), 1-25.
75. Recommendations for using smallpox vaccine in a pre-event vaccination program (2003) Supplemental recommendations of the Immunization Practices Advisory Committee (ACIP) and Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 52(RR-7), 1-15.
76. Prevention of hepatitis A through active or passive immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55(RR-7), 1-23.
77. Use of anthrax vaccine in the United States recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-15), 1-39.
78. Centers for Disease Control and Prevention (2002) Notice to readers: use of anthrax vaccine in response to terrorism: Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 51 1024-1026.
79. Use of vaccines and immune globulin in persons with altered immunocompetence recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 42(RR-4), 1-18.
80. L Loutan (1997) Vaccination of the immunocompromised patient. Biologicals 25 231-236.
81. L-A Pirofski and A Casadevall (1998) Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 11 1-26.
82. Weber DJ, Weigle K, Rutala WA. Immunization of workers with altered host defenses. In Poland GA, Schaffner W, Publiese G (eds). Immunizing Healthcare Workers: A Practical Approach. Thorofare, NJ, Slack, 2000.
83. Centers for Disease Control and Prevention (2002) Guidelines for preventing opportunistic infections among HIV-infected persons—2002. MMWR 51(RR-8), 1-51.
84. DJ Weber and WA Rutala (2003) Immunizations in immunocompromised persons. Immunol Allergy Clinic North Am 23 605-634.
85. M Plescia and L Leach (2005) What illnesses contraindicate immunization? J Fam Prac 54 621-623.
86. FM Munoz and JA Englund (2001) Vaccines in pregnancy. Infect Dis Clin North Am 15 253-271.
87. RG Faix (2002) Immunization during pregnancy. Clin Obstet Gynecol 45 42-58.
88. SA Gall (2003) Maternal immunization. Obstet Gynecol Clin North Am 30 623-636.
89. J Tillet (2004) The use of vaccines in pregnancy. J Perinat Neonat Nurs 18 216-229.
90. Guidelines for vaccinating pregnant women recommendations of the Advisory Committee on Immunization Practices (ACIP). www.cdc.gov/vaccines/pubs/preg-guide.htm Updated May 2007, accessed 10/29/2007
91. RL Brent (2006) Risks and benefits of immunizing pregnant women: the risk of doing nothing. Reproductive toxicology 21 383-389.
92. Centers for Disease Control and Prevention Recommended childhood and adolescent immunization schedule, United States, 2006. www.cdc.gov/nip/recs/child-schedule-bw-print.pdf Accessed June 1, 2006
93. Update vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45(RR-12), 1-35.
94. RM Altas (1998) The medical threat of biological weapons. Crit Rev Microbiol 24 157-168.
95. DA Henderson (1999) The looming threat of bioterrorism. Science 283 1279-1282.
96. RJ Leggiadro (2000) The threat of biological terrorism: a public health and infection control reality. Infect Control Hosp Epidemiol 21 53-56.
97. Biological and chemical terrorism (2000) Strategic plan for preparedness and response. MMWR 49(No. RR-4), 1-63.
98. MJ World (2004) Bioterrorism: the need to be prepared. Clin Med 4 161-164.
99. DM Morens, GK Folkers and AS Fauci (2004) The challenge of emerging and re-emerging infectious disease. Nature 430 242-249.
100. C Gosden and D Gardener (2005) Weapons of mass destruction—threats and responses. BMJ 331 397-400.
101. Recognition of illness associated with the intentional release of a biologic agent (2001) MMWR 50 893-897.
102. DR Franz, PB Jahrling, DJ McClain, et al. (2001) Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 21 435-473.
103. DR Franz and R Zajtchuk (2002) Biological terrorism: understanding the threat, preparation, and medical response. Dis Mon 48 493-564.
104. JK Horn (2003) Bacterial agents used for bioterrorism. Surg Infect 2003 281-287.
105. M Karwa, B Currie and V Kvetan (2005) Bioterrorism: preparing for the impossible or the improbable. Crit Care Med 33(Suppl), S75-S95.
106. TV Inglesby, T O'Toole, DA Henderson, et al. (2002) Anthrax as a biological weapon, 2002: update recommendations for management. JAMA 287 2236-2252.
107. SS Arnon, R Schechter, TV Inglesby, et al. (2001) Botulinum toxin as a biological weapon: medical and public health consequences. JAMA 285 1059-1070.
108. TV Inglesby, DT Dennis, DA Henderson, et al. (2000) Plague as a biological weapon: medical and public health consequences. JAMA 283 2281-2290.
109. DA Henderson, TV Inglesby, JG Bartlett, et al. (1999) Smallpox as a biological weapon: medical and public health consequences. JAMA 281 2127-2137.
110. DT Dennis, TV Inglesby, DA Henderson, et al. (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285 2763-2773.
111. L Borio, T Inglesby, CJ Peters, et al. (2002) Hemorrhagic fever viruses as biological weapons. JAMA 287 2391-2405.
112. M Houston and RG Hendrickson (2005) Decontamination. Crit Care Med 21 653-672.
113. NC Ales and RK Katial (2004) Vaccines against biologic agents: uses and developments. Respir Care Clin N Am 10 123-146.
114. MJ Hassani, MC Patel and L Pirofski (2004) Vaccines for the prevention of diseases caused by potential bioweapons. Clin Immunol 111 1-15.
115. AD Horne, J Clifford, KL Goldenthal, C Kleppinger and PA Lachenbruch (2004) Preventive vaccines against bioterrorism: evaluation of efficacy and safety. Vaccine 23 84-90.
116. DM Altmann (2005) Developing vaccines to counter bioterrorist threats. Expert Rev Vaccines 4 275-279.
117. GA Poland and KL Nichol (1990) Medical schools and immunization policies: missed opportunities for disease prevention. Ann Intern Med 113 628-631.
118. R Lewy (1988) Immunization status of entering housestaff physicians. J Occup Med 30 822-823.
119. S Schwarcz, B McCaw and P Fukushima (1992) Prevalence of measles susceptibility in hospital staff. Arch Intern Med 152 1481-1483.
120. BH Stover, G Adams, CA Kuebler, et al. (1994) Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy. Infect Control Hosp Epidemiol 15 18-21.
121. ME Willy, DE Koziol, T Fleisher, et al. (1994) Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 15 12-17.
122. LJ Wright and JF Carlquist (1994) Measles immunity in employees of a multihospital healthcare provider. Infect Control Hosp Epidemiol 15 8-11.
123. KG Huang, MR Spence, A Deforest and AT Bradley (1994) Measles immunization in HCWs. Infect Control Hosp Epidemiol 15 4.
124. DP Ewert, D Garcia, J George and L Mascola (1995) A comparison of hospital policies for measles, mumps, and rubella infection control in Los Angeles County, 1989 and 1992. Am J Infect Control 23 369-372.
125. NE Lane, RI Paul, DF Bratcher and BH Stover (1997) A survey of policies at children's hospitals regarding immunity of healthcare workers: are physicians protected? Infect Control Hosp Epidemiol 18 400-404.
126. SK Seo, SF Malak, S Lim, et al. (2002) Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1998–1999. Infect Control Hosp Epidemiol 23 276-278.
127. S Weingarten, M Riedinger, LB Bolton, et al. (1989) Barriers to influenza vaccine acceptance. Am J Infect Control 17 202-207.
128. CN Shapiro, JI Tokars and ME Chamberland (1996) Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopedic surgeons. J Bone Joint Surg 78 1791-1800.
129. MA McArthur, AE Simor, B Campbell and A McGeer (1995) Influenza and pneumococcal vaccination and tuberculin skin testing programs in long-term care facilities: where do we stand? Infect Control Hosp Epidemiol 16 18-24.
130. MA McArthur, AE Simor, B Campbell and A McGreer (1999) Influenza vaccination in long-term-care facilities: structuring programs for success. Infect Control Hosp Epidemiol 20 499-503.
131. AL Panlilio, CN Shapiro, CA Schable, et al. (1995) Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. J Am Coll Surg 180 16-24.
132. TB Agerton, FJ Mahoney, LB Polish and CN Shapiro (1995) Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine. Infect Control Hosp Epidemiol 16 287-291.
133. JL Cleveland (1996) Hepatitis B vaccination and infection among U.S. dentists, 1983–1993. J Am Dent Assoc 127 1385-1390.
134. AO Fatusi, OA Fatusi, AO Esimai, AA Onayade and OS Ojo (2000) Acceptance of hepatitis B vaccine by workers in a Nigerian teaching hospital. East African Med J 77 608-612.
135. KL Nichol and M Hauge (1997) Influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 18 189-194.
136. P Gyawali, PS Rice and AJ Tilzey (1998) Exposure to blood borne viruses and the hepatitis B vaccination status among healthcare workers in inner London. Occup Environ Med 55 570-572.
137. FJ Mahoney, K Stewart, H Hu, P Coleman and MJ Alter (1997) Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 157 2601-2605.
138. MM Zadeh, CB Bridges, WW Thompson, et al. (2000) Influenza outbreak detection and control measures in nursing homes in the United States. J Am Geriatr Soc 48 1310-1315.
139. R Vranckx, P Jacques, A de Schirijver and G Moens (2004) Hepatitis B vaccination coverage in Belgian health care workers. Infection 32 278-281.
140. XW Cui, MM Nagao and PV Effler (2001) Influenza and pneumococcal vaccination coverage levels among Hawaii statewide long-term-care facilities. Infect Control Hosp Epidemiol 22 519-521.
141. ML Russell (2001) Influenza vaccination in Alberta long-term care facilities. CMAJ 164 1423-1427.
142. CG Stevenson, MA McArthur, M Naus, et al. (2001) Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing? CMAJ 164 1413-1419.
143. RRM Gershon, C Mitchell, MF Sherman, et al. (2005) Hepatitis B vaccination in correctional health care workers. Infect Control Hosp Epidemiol 33 510-518.
144. SB Murray and SA Skull (2002) Poor health care worker vaccination coverage and knowledge of vaccination recommendations in a tertiary care Australia hospital. Aust N Z J Public Health 26 65-68.
145. RA Martinello, L Jones and JE Topal (2003) Correlation between healthcare workers’ knowledge of influenza vaccine and vaccine receipt. Infect Control Hosp Epidemiol 24 845-847.
146. C O'Rorke, W Bourke, D Bedford and F Howell (2003) Uptake of influenza vaccine by healthcare workers in an acute hospital in Ireland. Ir Med J 96 207-209.
147. KA Bryant, B Stover, L Cain, GL Levine, J Siegel and WR Jarvis (2004) Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 25 912-917.
148. FW O'Reilly, GW Cran and AB Stevens (2005) Factors affecting influenza vaccine uptake among health care workers. Occupational Med 55 474-479.
149. HS Canning, J Phillips and S Allsup (2005) Health care worker beliefs about influenza vaccine and reasons for non-vaccination—a cross-sectional survey. J Clin Nursing 14 922-925.
150. AP Wodi, S Samy, E Ezeanolue, et al. (2005) Influenza vaccine: immunization rates, knowledge, and attitudes of resident physicians in an urban teaching hospital. Infect Control Hosp Epidemiol 26 867-873.
151. WC Toy, JE Janosky and SB Laird (2005) Influenza immunization of medical residents: knowledge, attitudes, and behaviors. Am J Infect Control 33 473-475.
152. S-M Alavian, H Akbari, M Ahmadzad-Asl, M Kazem, A Davoudi and H Tavangar (2005) Concerns regarding dentists’ compliance in hepatitis B vaccination and infection control. Am J Infect Control 33 428-429.
153. MA Christian (1991) Influenza and hepatitis B vaccine acceptance: a survey of healthcare workers. Am J Infect Control 19 177-184.
154. MW Mah, NA Hagen, K Pauling-Shepard, et al. (2005) Understanding influenza vaccination attitudes as a Canadian cancer center. Am J Infect Control 33 243-250.
155. AO Goldstein, JE Kincade, G Gamble and RS Bearman (2005) Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol 25 908-911.
156. KA Adal, RH Flowers, AM Anglim, et al. (1996) Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 17 641-648.
157. CD Salgado, ET Giannetta, FG Hayden and BM Farr (2004) Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 25 923-928.
158. Centers for Disease Control and Prevention (2005) Interventions to increase influenza vaccination of health-care workers—California and Minnesota. MMWR 54 196-199.
159. JF Hallauer and N Neuschaefer-Rube (2005) Influenza vaccination of hospital staff in Germany: a five-year survey on vaccination coverage and policies: identified deficits in influenza immunization campaigns for hospital employees. Soz Praventimed 50 38-44.
160. T Tapiainen, G Bar, UB Schaad and U Heininger (2005) Influenza vaccination among healthcare workers in a university children's hospital. Infect Control Hosp Epidemiol 26 855-858.
161. JA McCullers, KM Speck, BF Williams, H Liang and J Mirro (2006) Increased influenza vaccination of healthcare workers at a pediatric cancer hospital: results of a comprehensive influenza vaccination campaign. Infect Control Hosp Epidemiol 27 77-79.
162. Summary of notifiable diseases, United States, 2004. MMWR 53 1-47.
163. FH Thomson (1916) The aerial conveyance of infection. Lancet 1 341-344.
164. PA Brunell, A Brickman, D O'Hare and S Steinberg (1968) Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. N Engl J Med 279 1357-1361.
165. D Sparling (1969) Transmission of mumps. N Engl J Med 280 276.
166. JL Faoagali (1976) An assessment of the need for vaccination amongst junior medical staff. N Z Med J 84 150-152.
167. D Glick (1970) An isolated case of mumps in a geriatric population. J Am Geriatr Soc 18 642-644.
168. M Wharton, SL Cochi, RH Hutcheson and W Schaffner (1990) Mumps transmission in hospitals. Arch Intern Med 150 47-49.
169. PR Fischer, C Brunetti, V Welch and JC Christenson (1996) Nosocomial mumps: report of an outbreak and its control. Am J Infect Control 24 13-18.
170. D Reed, G Brown, R Merrick, et al. (1967) A mumps epidemic on St. George Island, Alaska. JAMA 84 113-117.
171. RK Gupta, J Best and E MacMahon (2005) Mumps and the UK epidemic 2005. BMJ 330 1132-1135.
172. M Donaghy, JC Cameron and V Friederichs (2006) Increasing incidence of mumps in Scotland: options for reducing transmission. J Clin Virol 35 121-129.
173. Centers for Disease Control and Prevention (2006) Mumps epidemic—United Kingdom, 2004–2005. MMWR 55 173-175.
174. Centers for Disease Control and Prevention (2006) Update: multistate outbreak of mumps—United States, January 1–May 2, 2006. MMWR 55 559-563.
175. Centers for Disease Control and Prevention (2006) Mumps epidemic—Iowa, 2006. MMWR 55 366-368.
176. Mumps outbreak recommendations (2006) Med Lett Drug Ther 48 45.
177. Measles-Texas. MMWR 30 209-211.
178. Measles in medical settings-United States (1981) MMWR 30 125-126.
179. Imported measles with subsequent airborne transmission in a pediatrician's office-Michigan. MMWR 32 401-403.
180. Measles among children of migrant workers-Florida (1983) MMWR 32 471. 472, 477, 478
181. Interstate transmission of measles in a gypsy population-Washington, Idaho, Montana, California. MMWR 32 659-662.
182. Measles-Hawaii. MMWR 33 702. 707–711
183. Measles-New Hampshire. MMWR 33 549-554. 559
184. PL Remington, WN Hall, IH Davis, et al. (1985) Airborne transmission of measles in a physician's office. JAMA 253 1574-1577.
185. AB Bloch, WA Orenstein, WM Ewing, et al. (1985) Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 75 676-683.
186. Measles-Puerto Rico. MMWR 34 169-172.
187. LG Dales and KW Kizer (1985) Measles transmission in medical facilities. West J Med 142 415-416.
188. RM Davis, WA Orenstein, JA Frank, et al. (1986) Transmission of measles in medical settings: 1980 through 1984. JAMA 255 1295-1298.
189. GR Istre, PA McKee, GR West, et al. (1987) Measles spread in medical settings: an important focus of disease transmission. Pediatrics 79 356-358.
190. NM Watkins, RP Smith Jr, DL Germain St and DN MacKay (1987) Measles (rubeola) infection in a hospital setting. Am J Infect Control 15 201-206.
191. DG Sienko, C Friedman, HB McGee, et al. (1987) A measles outbreak at university medical settings involving healthcare providers. Am J Public Health 77 1222-1224.
192. Measles transmitted in a medical office building-New Mexico, 1986. MMWR 36 25-27.
193. Measles-Dade County Florida (1987) MMWR 36 45-48.
194. Measles-Los Angeles County (1989) California, 1988. MMWR 38 49-52. 57
195. LE Markowitz, SR Preblud, WA Orenstein, et al. (1989) Patterns of transmission in measles outbreaks in the United States, 1985–1986. N Engl J Med 320 75-81.
196. Anonymous (1982) Measles nearly eliminated, but still poses a nosocomial risk. Hosp Infect Control 9 133-136.
197. II Raad, RJ Sherertz, CS Rains, et al. (1989) The importance of nosocomial transmission of measles in the propagation of a community outbreak. Infect Control Hosp Epidemiol 10 161-166.
198. Measles-Washington, 1990. MMWR 39 473-476.
199. KM Farizo, PA Stehr-Green, DM Simpson, et al. (1991) Pediatric emergency room visits: a risk factor for acquiring measles. Pediatrics 87 74-79.
200. WL Atkinson, LE Markowitz, NC Adams, et al. (1991) Transmission of measles in medical settings-United States, 1985–1989. Am J Med 91(Suppl 3B), 320S-324S.
201. ME Rivera, WH Mason, HT Wright Jr and LA Ross (1991) Nosocomial measles infection in a pediatric hospital during a community-wide epidemic. J Pediatr 119 183-186.
202. D McGrath, R Swanson, S Weems, et al. (1992) Analysis of a measles outbreak in Kent County, Michigan in 1990. Pediatr Infect Dis J 11 385-389.
203. PC Freebeck, S Clark and PJ Fahey (1992) Hypoxemic respiratory failure complicating nosocomial measles in a healthy host. Chest 102 625-626.
204. AC Miranda, JM Falcao, JA Dias, et al. (1994) Measles transmission in health facilities during outbreaks. Int J Epidemiol 23 843-848.
205. J Ward and O El-Saadi (1999) Measles in the waiting room: a cautionary tale. Aust Fam Physician 28 1103.
206. RL de Swart, PME Wertheim-van Dillen, RS van Binnendijk, et al. (2000) Measles in a Dutch hospital introduced by an immunocompromised infant from Indonesia infected with an new virus genotype. Lancet 355 201-202.
207. GMS Mendelson, CE Roth, TG Wreghitt, et al. (2000) Nosocomial transmission of measles to healthcare workers: time for a national screening and immunization policy for NHS staff? J Hosp Infect 44 154-155.
208. KV Blake, OTK Nguyen and AG Capon (2001) Nosocomial transmission of measles in western Sydney. Med J Aust 175 442.
209. RJ Biellik and CJ Clements (1997) Strategies for minimizing nosocomial measles transmission. Bull World Health Organ 75 367-375.
210. T Nakano, T Ihara and H Kamiya (2002) Measles outbreak among non-immunized children in a Japanese hospital. Scand J Infect Dis 34 426-429.
211. TM Marshall, D Hlatswayo and Schoub (2003) Nosocomial outbreaks—a potential threat to the elimination of measles. J Infect Dis 187(Suppl 1), S97-S101.
212. Rubella in contacts of infants with rubella-associated anomalies. MMWR 14 44-45.
213. GM Schiff and MS Dine (1965) Transmission of rubella from newborns. Am J Dis Child 110 447-451.
214. JW Giles and IM Smith (1972) The study of a rubella outbreak. J Iowa Med Soc 62 238-341.
215. S Carne, CJ Dewhurst and R Hurley (1973) Rubella epidemic in a maternity unit. Br Med J 1 444-446.
216. K Baba, H Yabuuchi, H Okuni, et al. (1978) Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups. Biken J 21 25-31.
217. Exposure of patients to rubella by medical personnel-California. MMWR 27 123.
218. Rubella in hospital personnel and patients-Colorado. MMWR 28 325-327.
219. MC McLaughlin and LH Gold (1979) The New York rubella incident: a case for changing hospital policy regarding rubella testing and immunization. Am J Public Health 69 287-289.
220. BF Polk, JA White, PC DeGirolami and JF Modlin (1980) An outbreak of rubella among hospital personnel. N Engl J Med 303 541-545.
221. Nosocomial rubella infection-North Dakota, Alabama, Ohio. MMWR 29 629-631.
222. JL Gladstone and SJ Millian (1981) Rubella exposure in an obstetric clinic. Obstet Gynecol 57 182-186.
223. MA Strassburg, DT Imagawa, SL Fannin, et al. (1981) Rubella outbreak among hospital employees. Obstet Gynecol 57 283-288.
224. Rubella in hospitals-California. MMWR 32 37-39.
225. MA Strassburg, TG Stephenson, LA Habel and SL Fannin (1984) Rubella in hospital employees. Infect Control 5 123-126.
226. PNR Heseltine, M Ripper and P Wohlford (1985) Nosocomial rubella-consequences of an outbreak and efficacy of a mandatory immunization program. Infect Control 6 371-374.
227. GA Storch, C Gruber, B Benz, et al. (1985) A rubella outbreak among dental students: description of the outbreak and analysis of control measures. Infect Control 6 150-156.
228. JT Jacobson (1987) Rubella: one hospital's experience. Am J Infect Control 15 136-137.
229. GA Poland and KL Nichol (1990) Medical students as sources of rubella and measles outbreaks. Arch Intern Med 150 44-46.
230. E Sheridan, C Aitken, D Jeffries, et al. (2002) Congenital rubella syndrome: a risk for immigrant populations. Lancet 359 674-675.
231. Y Nerome, J Nishi, R Fujiyama, S Takei, M Yoshinaga and Y Kawano (2004) An outbreak of rubella among hospital personnel and measures taken against hospital infection—cost-benefits of the measure. Kansenshogaku Zasshi 78 967-974.
232. H Braunstein, S Thomas and R Ito (1990) Immunity to measles in a large population of varying age. Am J Dis Child 144 296-298.
233. E Smith and VK Wong (1993) Measles susceptibility of hospital personnel. Arch Intern Med 153 1011.
234. BS Hersh, PE Fine, WK Kent, et al. (1991) Mumps outbreaks in a highly vaccinated population. J Pediatr 119 187-193.
235. AM Arvin (1996) Varicella-zoster virus. Clin Microbiol Rev 9 361-381.
236. JI Cohen (1996) Varicella-zoster virus. Infect Dis Clin North Am 10 457-468.
237. AM Arvin (1999) Chickenpox (varicella). Contrib Microbiol 3 96-110.
238. ML McCrary, J Severson and SK Tyring (1999) Varicella zoster virus. J Am Acad Dermatol 41 1-14.
239. BK Kleinschmidt-DeMasters and DH Gilden (2001) Varicella-zoster virus infections of the nervous system. Arch Pathol Lab Med 125 770-780.
240. JW Gnann Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186(Suppl 1), S91-S98.
241. TM Chen, S George, CA Woodruff and S Hsu (2002) Clinical manifestations of varicella-zoster virus infection. Dermatol Clin 20 267-282.
242. JW Gnann Jr and RJ Whitley (2002) Herpes zoster. New Engl J Med 347 340-346.
243. DE Dwyer and AL Cunningham (2002) 10: Herpes simplex and varicella-zoster virus infections. MJA 177 267-273.
244. RH Dworkin and KE Schmader (2003) Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 36 877-882.
245. R English (2003) Varicella. Pediat Rev 24 372-379.
246. TJ Liesegang (2004) Herpes zoster virus infection. Curr Opin Ophthalmol 15 531-536.
247. D Gilden (2004) Varicella zoster virus and central nervous system syndromes. Herpes 11(Suppl 2), 89A-94A.
248. S Hambleton and AA Gershon (2005) Preventing Varicella-zoster disease. Clin Microbiol Rev 18 70-80.
249. S Hambleton (2005) Chickenpox. Curr Opin Infect Dis 18 235-240.
250. Decline in annual incidence of varicella-selected states, 1990–1991. MMWR 52 884-885.
251. S Hambleton and AA Gershon (2005) The impact of varicella vaccination in the United States. Semin Pediatr Infect Dis 16 38-43.
252. HQ Nguyen, AO Jumaan and JF Seward (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New Engl J Med 352 450-458.
253. C Grose (2005) Varicella vaccination of children in the United States: assessment after the first decade 1995–2005. J Clin Virol 33 89-95.
254. WK Yih, DR Brooks, SM Lett, et al. (2005) The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella coverage, 1998–2003. BMC Pubic Health 5 68.
255. F Zhou, R Harpaz, AO Jumaan, CA Winston and A Shefer (2005) The impact of varicella vaccination on health care utilization. JAMA 294 797-802.
256. MA Staat, J Meinzen-Derr, T Welch, et al. (2006) Variceilla-related hospitalization and emergency department visit rates, before and after introduction of the varicella vaccine, among white and black children in Hamilton County, Ohio. Pediatr 117 e833-e839.
257. RL Brawley and RP Wenzel (1984) An algorithm for chickenpox exposure. Pediatr Infect Dis 3 502-504.
258. MR Weitekamp, P Schan and RC Aber (1985) An algorithm for the control of nosocomial varicella-zoster virus infection. Am J Infect Control 13 193-198.
259. MR Sayre and EJ Lucid (1987) Management of varicella-zoster virus-exposed hospital employees. Ann Emerg Med 16 421-424.
260. DJ Weber, WA Rutala and C Parham (1988) Impact and costs of varicella prevention in a university hospital. Am J Public Health 78 19-23.
261. DH Stover and DF Bratcher (1998) Varicella-zoster virus: infection, control, and prevention. Am J Infect Control 26 369-384.
262. SM Burns, N Mitchell-Heggs and D Carrington (1998) Occupational and infection control aspects of varicella. J Infect 36(Suppl 1), 73–78.
263. DJ Weber and WA Rutala (2000) A varicella immunization program. GA Poland, W Schaffner, G Pugliese (Eds) Immunizing Healthcare Workers: A Practical Approach Thorofare, NJ: Slack 243-260.
264. REH Simpson (1952) Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 2 549-554.
265. AH Ross (1962) Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 267 369-376.
266. A Josephson, L Karanfil and ME Gombert (1990) Strategies for the management of varicella-susceptible healthcare workers after a known exposure. Infect Control Hosp Epidemiol 11 309-313.
267. JF Seward, JX Zhang, TJ Maupin, L Mascola and AO Jumaan (2004) Contagiousness of varicella in vaccinated cases: a household contact study. JAMA 292 704-708.
268. SJ Chapman (1998) Varicella in pregnancy. Semin Perinatol 22 339-346.
269. A Sauerbrei and P Wutzler (2000) The congenital varicella syndrome. J Perinatol 20 548-554.
270. DE McCarter-Spaulding (2001) Varicella infection in pregnancy. J Obstet Gynecol Neonatal Nurs 30 667-673.
271. MR Schleiss (2003) Vertically transmitted herpes virus infections. Herpes 10 4-11.
272. G Koren (2005) Congenital varicella syndrome in the third trimester. Lancet 366 1591-1592.
273. MP Tan and G Koren (2006) Chickenpox in pregnancy: revisited. Reproductive Toxicol 21 410-420.
274. M Wharton (1996) The epidemiology of varicella-zoster virus infection. Infect Dis Clin North Am 10 571-581.
275. PW Choo, JG Donahue, JE Manson and R Platt (1995) The epidemiology of varicella and its complications. J Infect Dis 172 706-712.
276. E Miller, R Marshall and J Vurdien (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4 222-230.
277. S Feldman, WT Hughes and CB Daniel (1975) Varicella in children with cancer: seventy-seven cases. Pediatrics 56 388-397.
278. CM Feldhoff, HH Balfour, RL Simmons, et al. (1981) Varicella in children with renal transplants. J Pediatr 98 25-31.
279. RM Locksley, N Flournoy, KM Sullivan and JD Meyers (1985) Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 152 1172-1181.
280. JD Meyers, MB MacQuarrie, TC Merigan and MH Jennison (1979) Nosocomial varicella: Part 1. Outbreak in oncology patients at a children's hospital. West J Med 130 196-199.
281. ER Morgan and LA Smalley (1983) Varicella in immunocompromised children. Am J Dis Child 137 883-885.
282. R Whitley, M Hilty, R Haynes, et al. (1982) Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr 101 125-131.
283. S Feldman and L Lott (1987) Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 80 255-262.
284. RS McGregor, BJ Zitelli, AH Urback, et al. (1989) Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 83 256-261.
285. AM Arvin (1999) Management of varicella-zoster virus infections in children. Adv Exp Med Biol 458 167-174.
286. GDW McKendrick and RTD Emond (1976) Investigation of cross-infection in isolation wards of different designs. J Hyg Camb 76 23-31.
287. DM Morens, DJ Bregman, CM West, et al. (1980) An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med 93 414-419.
288. JM Leclair, JA Zaia, MJ Levin, et al. (1980) Airborne transmission of chickenpox in a hospital. N Engl J Med 302 450-453.
289. D Scheifele and M Bonner (1980) Airborne transmission of chickenpox [letter]. N Engl J Med 303 281-282.
290. Y Asano, S Iwayama, T Miyata, et al. (1980) Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 23 157-161.
291. R Faizallah, HT Green, N Krasner and RJ Walker (1982) Outbreak of chickenpox from a patient with immunosuppressed herpes zoster in hospital. Br Med J (Clin Res Ed) 285 1022-1023.
292. PJ Hyams, MCS Stuewe and V Heitzer (1984) Herpes zoster causing varicella (chickenpox) in hospital employees: cost of a casual attitude. Am J Infect Control 12 2-5.
293. G Tsujino, M Sako and M Takahashi (1984) Varicella infection in a children's hospital: prevention by vaccine and an episode of airborne transmission. Biken J 27 129-132.
294. TL Gustafson, Z Shehab and PA Brunell (1984) Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child 138 548-550.
295. JD Anderson, M Bonner, DW Schiefele and BC Schneider (1985) Lack of nosocomial spread of varicella in a pediatric hospital with negative pressure ventilated patient rooms. Infect Control 6 120-121.
296. K Krasinski, RS Holzman, R LaCouture and A Florman (1986) Hospital experience with varicella-zoster virus. Infect Control 7 312-316.
297. A Josephson and M Gombert (1988) Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 158 238-241.
298. BH Stover, KM Cost, C Hamm, et al. (1988) Varicella exposure in a neonatal intensive care unit: case report and control measures. Am J Infect Control 16 167-172.
299. CA Friedman, DM Temple, KK Robbins, et al. (1994) Outbreak and control of varicella in a neonatal intensive care unit. Pediatr Infect Dis J 13 152-153.
300. JL Faoagali and D Darcy (1995) Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control. Am J Infect Control 23 247-250.
301. J Kavaliotis, I Loukou, M Trachana, et al. (1998) Outbreak of varicella in a pediatric oncology unit. Med Pediatr Oncol 31 166-169.
302. RL Sheridan, JL Weber, MM Pasternak, JM Mulligan and RG Tompkins (1999) A 15-year experience with varicella infections in a pediatric burn unit. Burns 25 353-356.
303. JW Tang, I Eames, Y Li, et al. (2005) Door-opening motion can potential lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyanc airflows. J Hosp Infect 61 283-286.
304. MH Sawyer, CJ Chamberlin, YN Wu, et al. (1994) Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 169 91-94.
305. T Yoshikawa, M Ihira, K Suzuki, et al. (2001) Rapid contamination of the environment with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol 63 64-66.
306. JM Lyznicki, RJ Bezman and M Genel (1998) Report of the Council on Scientific Affairs, American Medical Association: immunization of healthcare workers with varicella vaccine. Infect Control Hosp Epidemiol 19 348-353.
307. CN Holmes (2005) Predictive value of a history of varicella infection. Canadian Fam Phy 51 60-65.
308. Varicella vaccine FAQs about health care workers. www.cdc.gov/nip/vaccine/varicella/faqa-clinic-vac-hcw.htm Accessed June 1, 2006
309. MD Nettleman and M Schmid (1997) Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers. Infect Control Hosp Epidemiol 18 504-508.
310. AM Gray, P Fenn, J Weinberg, et al. (1997) An economic analysis of varicella vaccination for health care workers. Epidemiol Infect 119 209-220.
311. AM Tennenberg, JF Brassard, JV Lieu and LM Drusin (1997) Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits. Infect Control Hosp Epidemiol 18 405-411.
312. L Saiman, P LaRussa, SP Steinberg, et al. (2001) Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol 22 279-283.
313. A new product (VariZIG™) for postexposure prophylaxis of varicella available under an investigational new drug application expanded pool protocol. MMWR 55 209-210.
314. Y Asano, T Yoshikawa, S Suga, et al. (1993) Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92 219-222.
315. S Suga, T Yoshikawa, T Ozaki and Y Asano (1993) Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 69 639-642.
316. S Suga, T Yoshikawa, T Yazaki, T Ozaki and Y Asano (1996) Dose-dependent effects of oral acyclovir in the incubation period of varicella. Acta Paediatr 85 1418-1421.
317. Y Asano, S Suga, T Yoshikawa and T Ozaki (1994) Prophylaxis or modification of varicella by oral acyclovir after household exposure. Arch Dis Child 70 451-452.
318. M Hayakawa, H Kimura, M Ohshiro, et al. (2003) Varicella exposure in a neonatal medical center: successful prophylaxis with oral acyclovir. J Hosp Infect 54 212-215.
319. T Kumagai, M Kamada, C Igarashi, et al. (1999) Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure. J Infect Dis 180 834-837.
320. T-Z Lin, Y-C Huang, H-C Ning and C Hsuen (1997) Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J 16 1162-1165.
321. Y Ishida, H Tauchi, A Higaki, Y Yokota-Outou and K Kida (1996) Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir. Pediatr 97 150-151.
322. SL Goldstein, MJG Somers, MB Lande, ED Brewer and KL Jabs (2000) Acyclovir prophyaxis of varicella in children with renal disease receiving steroids. Pediatr Nephol 14 305-308.
323. DM Weinstock, M Boeckh, F Bouland, et al. (2004) Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues. Infect Control Hosp Epidemiol 25 603-608.
324. T Yoshikawa, S Suga, T Kozawa, S Kawaguchi and Y Asano (1998) Persistence of protective immunity after postexposure prophylaxis of varicella with oral acyclovir in the family setting. Arch Dis Child 78 61-63.
325. I Hirose, H Ymamaguchi, D Inaguma, et al. (2006) Fatal varicella infection in a girl with systemic lupus erythematosis after oral acyclovir prophylaxis. Eur J Pediatr 165 280-281.
326. T Mori, T Shimizu, R Yamazaki, et al. (2006) Varicella-zoster virus infection under adminstration of ganciclovir after allogenic bone marrow transplantation. Scand J Infect Dis 38 227-228.
327. N Leveque, C Galambrun, F Najioullah, N Bleyzac, M-P Pages and Y Bertrand (2006) Two cases of varicella zoster virus meningitis found in pediatric patients after bone marrow transplantation despite valaciclovir prophylaxis and without skin lesions. J Med Virol 78 514-516.
328. K Ueda, I Yamada, M Goto, et al. (1977) Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MSLC (muco-cutaneous lymph node syndrome) patients in hospitals. Biken J 20 117-123.
329. N Katsushima, N Yazaki, M Sakamoto, et al. (1982) Application of a live varicella vaccine to hospitalized children and its follow-up study. Biken J 25 29-42.
330. Y Asano, S Hirose, S Iwayama, et al. (1982) Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination. Biken J 25 43-45.
331. N Katsushima, N Yazaki and M Sakamoto (1984) Effect and follow-up study of varicella vaccine. Biken J 27 51-58.
332. H Sugino, R Tsukino, E Miyashiro, et al. (1984) Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection. Biken J 27 63-65.
333. Y Naganuma, S Osawa and R Takahashi (1984) Clinical application of a live varicella vaccine (Oka strain) in a hospital. Biken J 27 59-61.
334. D Boda, K Bartyik, P Szuts and S Turi (1986) Active immunization of children exposed to varicella infection in a hospital ward using live attenuated varicella vaccine given subcutaneously or intracutaneously. Acta Paediatr Hung 27 252-352.
335. AM Arbeter, SE Starr and SA Plotkin (1986) Varicella vaccine studies in healthy children and adults. Pediatrics 78(Suppl), 748-756.
336. MJ Ferson (2001) Varicella vaccine in post-exposure prophylaxis. Commun Dis Intell 25 13-15.
337. MB Salzman and C Garcia (1998) Postexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J 17 256-257.
338. B Watson, J Seward, A Yang, et al. (2000) Postexposure effectiveness of varicella vaccine. Pediatr 105 84-88.
339. M Mor, L Harel, E Kahan and J Amir (2004) Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting—a pilot study. Vaccine 23 325-328.
340. J Jagger, J Hunt Brand-Elnaggar and RD Pearson (1988) Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med 319 284-288.
341. DM Bell, CN Shapiro, CA Ciesielski and ME Chamberland (1995) Preventing bloodborne pathogen transmission from health-care workers to patients. The CDC perspective. Surg Clin North Am 75 1189-1203.
342. DM Cardo and DM Bell (1997) Bloodborne pathogen transmission in healthcare workers. Infect Dis Clin North Am 11 331-346.
343. EM Beltrami, IT Williams, CN Shapiro and ME Chamberland (2000) Risks and management of blood-borne infections in health care workers. Clin Microbiol Rev 13 385-407.
344. Updated U. S. Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 50(RR-11), 1-52.
345. SE Beekmann and DK Henderson (2005) Protection of healthcare workers from bloodborne pathogens. Curr Opin Infect Dis 18 331-336.
346. HE Segal, CH Llewellyn, G Irwin, et al. (1976) Hepatitis B antigen and antibody in the U.S. Army: prevalence in healthcare personnel. Am J Public Health 66 667-671.
347. AE Denes, JL Smith, JE Maynard, et al. (1978) Hepatitis B infection in physicians: results of a nationwide seroepidemiologic survey. JAMA 239 210-212.
348. JL Dienstag and DM Ryan (1982) Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 115 26-39.
349. SC Hadler, IL Doto, JE Maynard, et al. (1985) Occupational risk of hepatitis B infection in hospital workers. Infect Control 6 24-31.
350. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep 38(SS-6), 1-37.
351. CN Shapiro (1995) Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 75 1047-1056.
352. AB Lowenfels, GP Wormser and R Jain (1989) Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg 124 1284-1286.
353. JI Tokars, ME Chamberland, CA Schable, et al. (1992) A survey of occupational blood contact and HIV infection among orthopedic surgeons. JAMA 268 489-494.
354. WW Bond, MS Favero, NJ Peterson, et al. (1981) Survival of hepatitis B virus after drying and storage for one week. Lancet 1 550-551.
355. GF Grady, VA Lee, AM Prince, et al. (1978) Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 138 625-638.
356. LM Seeff, EC Wright, HJ Zimmerman, et al. (1978) Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Ann Intern Med 88 285-293.
357. BG Werner and GF Grady (1982) Accidental hepatitis-B-surface-antigen-positive inoculations. Ann Intern Med 97 367-369.
358. MC Kew (1973) Possible transmission of serum (Australia-antigen-positive) hepatitis via the conjunctiva. Infect Immun 7 823-824.
359. DR Snydman, SH Hindman, MD Wineland, et al. (1976) Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients. Ann Intern Med 85 573-577.
360. J Jorgensen (1988) Silent hepatitis B immunization in laboratory technicians. Scand J Clin Lab Invest 48 333-336.
361. HH Handsfield, MJ Cummings and PD Swenson (1987) Prevalence of antibody to human immunodeficiency virus and hepatitis B surface antigen in blood samples submitted to a hospital laboratory. Implications for handling specimens. JAMA 18 3395-3397.
362. Hepatitis B associated with jet gun injection-California. MMWR 35 373-376.
363. IM Morris, DS Cattle and BJ Smits (1975) Endoscopy and transmission of hepatitis B. Lancet 2 1152.
364. I Oren, RC Hershow, E Ben-Porath, et al. (1989) A common-source outbreak of fulminant hepatitis B in a hospital. Ann Intern Med 110 691-698.
365. K Kidd-Ljunggren, E Broman, H Ekvall and O Gustavsson (1999) Nosocomial transmission of hepatitis B virus infection through multiple-dose virals. J Hosp Infect 43 57-62.
366. U Dumpis, Z Kovalova, J Jansons, et al. (2003) An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol 69 331-338.
367. Transmission of hepatitis B and C viruses in outpatient settings—New York, Oklahoma, and Nebraska, 2000–2002. MMWR 52 901-906.
368. An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. CMAJ 162 1127-1131.
369. Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device-California. MMWR 39 610-613.
370. C Douvin, D Simon, H Zinelabidine, et al. (1990) An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood sampling device. N Engl J Med 322 57.
371. LB Polish, CN Shapiro, F Bauer, et al. (1992) Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded fingerstick device. N Engl J Med 326 721-725.
372. JT Stapleton and SM Lemon (1992) Transmission of hepatitis B by a finger-stick device [letter]. N Engl J Med 327 497.
373. L Mendez, KR Reddy, RA Di Prima, LJ Jeffers and ER Schiff (1991) Fulminant hepatic failure due to acute hepatitis B and delta co-infection: probable bloodborne transmission associated with a spring-loaded fingerstick device. Am J Gastroenterol 86 895-897.
374. Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices-Ohio and New York City, 1996. MMWR 46 217-221.
375. JM Quale, D Landman, B Wallace, et al. (1998) Déjà vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med 105 296-301.
376. Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care-facilities-Mississippi, North Carolina, and Los Angeles County, California, 2003–2004. MMWR 54 220-223.
377. K De Schrijver, I Maes, P Van Damme, J Tersago, E Moes and M Van Ranst (2005) An outbreak of nosocomial hepatitis B virus infection in a nursing home for the elderly in Antwerp (Belgium). Acta Clin Belg 60 63-69.
378. RD Comstock, S Mallonee, JL Fox, et al. (2004) A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 25 576-583.
379. J Drescher, D Wagner, A Haverick, et al. (1994) Nosocomial hepatitis B virus infection in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 26 81-92.
380. JL Lauer, NA VanDrunen, HH Balfour Jr and JW Washburn (1979) Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis 140 513-516.
381. CP Pattison, DM Boyer, JE Maynard and PC Kelly (1974) Epidemic hepatitis in a clinical laboratory: Possible association with computer card handling. JAMA 230 854-857.
382. S Tanaka, M Yoshiba, S Iino, et al. (1992) A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 48 1972-1978.
383. DR Hardie, J Kannemeyer and LM Stannard (1996) DNA single strand conformation polymorphism identifies five defined strains of hepatitis B virus (HBV) during an outbreak of HBV infection in an oncology unit. J Med Virol 49 49-54.
384. Outbreaks of hepatitis B virus infection among hemodialysis patients-California, Nebraska, and Texas, 1994. MMWR 45 285-289.
385. L De Castro, NM Araujo, RR Sabino, et al. (2000) Nosocomial spread of hepatitis B virus in two hemodialysis units, investigated by restriction fragment length polymorphism analysis. Eur J Clin Microbiol Infect Dis 19 531-537.
386. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 50(RR-5), 1-63.
387. JI Tokars, MJ Arduino and MJ Alter (2001) Infection control in hemodialysis units. Infect Dis Clin North Am 15 797-812.
388. M Zuckerman (2002) Surveillance and control of blood-borne virus infections in haemodialysis units. J Hosp Infect 50 1-5.
389. F Fabrizi, S Bunnapradist and P Martin (2004) HBV infection in patients with end-stage renal disease. Semin Liver Dis 24(Suppl 1), 63-70.
390. TG Wreghitt (2004) Bloodborne virus infections in dialysis units: a mini-review. Commun Dis Public Health 7 92-93.
391. P-N Wong, T-T Fung, S-K Mak, et al. (2005) Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 20 1641-1651.
392. DJ Weber, KK Hoffmann and WA Rutala (1991) Management of the healthcare worker infected with human immunodeficiency virus: lessons from nosocomial transmission of hepatitis B virus. Infect Control Hosp Epidemiol 12 625-630.
393. R Harpaz, L Von Seidlein, FM Averhoff, et al. (1996) Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 334 549-554.
394. Incident Investigation Team, et al. (1997) Transmission of hepatitis B to patients from four infected surgeons without hepatitis B ‘e’ antigen. N Engl J Med 336 178-184.
395. AIDS/TB Committee of the Society for Healthcare Epidemiology of America (1997) Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol 18 349-363.
396. RN Gunson, D Shouval, M Roggendorf, et al. (2003) Hepatitis B virus (HBV) and hepatitis C (HCV) infections in health car workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 27 213-230.
397. SM Lemon and DL Thomas (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336 196-204.
398. RS Koff (2001) Hepatitis vaccines. Infect Dis Clin North Am 15 83-95.
399. FJ Mahoney (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12 351-356.
400. Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. The Cochrane Database of Systematic Reviews, 2005.
401. RC Wood, KL MacDonald, KE White, et al. (1993) Risk factors for lack of detectable antibody following hepatitis B vaccination on Minnesota health care workers. JAMA 270 2935-2939.
402. W Jilg, M Schmidt and F Deinhardt (1989) Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 160 766-769.
403. RB Wainwright, BJ McMahon, LR Bulkow, et al. (1989) Duation of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 261 2362-2366.
404. SC Hadler, A de Monzon, DR Lugo and M Perez (1989) Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 7 106-110.
405. CT Leach (2004) Hepatitis A in the United States. Pediatr Infect Dis 23 551-552.
406. HB Jenson (2004) The changing picture of hepatitis A in the United States. Curr Opin Pediatr 16 89-93.
407. G Chodick, S Ashkenazi and Y Lerman (2006) The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies. J Hosp Infect 62 414-420.
408. AB Eisenstein, RD Aach, W Jacobson and A Goldman (1993) An epidemic of infectious hepatitis in a general hospital: probable transmission by contaminated orange juice. JAMA 185 171-184.
409. JD Meyers, JC Huff, KK Holmes, ED Thomas and JA Bryan (1974) Parenterally transmitted hepatitis A associated with platelet transfusions. Epidemiologic study of an outbreak in a marrow transplantation center. Ann Intern Med 81 145-151.
410. JD Meyers, FJ Romm, WS Tihen and JA Bryan (1975) Food-borne hepatitis A in a general hospital: epidemiologic study of an outbreak attributed to sandwiches. JAMA 231 1049-1053.
411. B Tufvesson, J van der Veen, W Duermeyer, PM Niklasson and T Johnsson (1979) An outbreak of hepatitis A investigated by immune electron microscopy and enzyme-linked immunosorbent assay. Scand J Infect Dis 11 97-98.
412. S Seeberg, A Brandberg, S Hermadsson, P Larsson and S Lundgren (1981) Hospital outbreak of hepatitis A secondary to blood exchange in a baby. Lancet 23 1155-1156.
413. GJ Papaevangelou, AJ Roumeliotou-Karayannis and PC Contoyannis (1981) The risk of hepatitis A and B virus infections from patients under care without isolation precaution. J Med Virol 7 143-148.
414. WA Orenstein, E Wu, J Wilkins, et al. (1981) Hospital-acquired hepatitis a: report of an outbreak. Pediatr 67 494-497.
415. RA Goodman, CC Carder, JR Allen, et al. (1982) Nosocomial hepatitis A transmission by an adult patient with diarrhea. Am J Med 73 220-226.
416. MS Krober, JW Bass, JD Brown, et al. (1984) Hospital outbreak of hepatitis A: risk factors for spread. Pediatr Infect Dis J 3 296-299.
417. BS Klein, JA Michaels, MW Rytel, et al. (1984) Nosocomial hepatitis A: a multinursery outbreak in Wisconsin. JAMA 252 2716-2721.
418. CM Reed, TL Gustafson, J Siegel, et al. (1984) Nosocomial transmission of hepatitis A from a hospital-acquired case. Pediatr Infect Dis J 3 300-303.
419. RC Noble, MA Kane, SA Reeves and I Roeckel (1984) Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 16 2711-2715. 252
420. RA Goodman (1985) Nosocomial hepatitis A. Ann Intern Med 103 452-454.
421. SJ Skidmore, PR Gully, JD Middleton, et al. (1985) An outbreak of hepatitis A on a hospital ward. J Med Virol 17 175-177.
422. PH Azimi, RR Roberto, J Guralnik, et al. (1986) Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child 140 23-27.
423. R Baptiste, DE Koziol and DK Henderson (1987) Nosocomial transmission of hepatitis A in an adult population. Infect Control 8 364-370.
424. LM Drusin, M Sohmer, SL Groshen, et al. (1987) Nosocomial hepatitis A infection in a pediatric intensive care unit. Arch Dis Child 62 690-695.
425. BS Klein, JA Michaels, MW Rytel, KG Berg and JP David (1984) Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA 252 2716-2721.
426. GP Giacoia and DO Kasprisin (1989) Transfusion-acquired hepatitis A. South Med J 82 1357-1360.
427. LS Rosenblum, ME Villarino, OV Nainan, et al. (1991) Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 164 476-482.
428. KK Lee, LR Vargo, CT Le and L Fernando (1992) Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. Pediatr Infect Dis J 11 122-123.
429. JC Watson, DC Flemming, AJ Borella, et al. (1993) Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis 167 567-571.
430. BN Doebbling, N Li and RP Wenzel (1993) An outbreak of hepatitis A among healthcare workers: risk factors for transmission. Am J Public Health 83 1679-1684.
431. BT Burkholder, VG Coronado, J Brown, et al. (1995) Nosocomial transmission of hepatitis A in a pediatric hospital traced to an anti-hepatitis A virus-negative patient with immunodeficiency. Pediatr Infect Dis J 14 261-266.
432. JN Hanna, MR Loewenthal, P Negel and DJ Wenck (1996) An outbreak of hepatitis A in an intensive care unit. Anaesth Intensive Care 24 440-444.
433. M Jensenius, SH Ringertz, H Bell, et al. (1998) Prolonged nosocomial outbreak of hepatitis A arising from an alcoholic with pneumonia. Scand J Infect Dis 30 119-123.
434. N Petrosillo, B Raffaele, L Martini, et al. (2002) A nosocomial and occupational cluster of hepatitis A virus infection in a pediatric word. Infect Control Hosp Epidemiol 23 343-345.
435. Surveillance for influenza—United States, 1997–98, 1998–99, and 1999–00 seasons. MMWR 51(SS-7), 1-10.
436. WH Barker (1986) Excess pneumonia and influenza associated hospitalizations during influenza epidemics in the United States, 1970–78. Am J Public Health 76 761-765.
437. D Fleming (2005) Influenza pandemics and avian flu. BMJ 331 1066-1069.
438. AS Fauci (2006) Pandemic influenza threat and preparedness. Emerg Infect Dis 12 73-77.
439. J-P Lui (2006) Avian influenza—a pandemic waiting to happen? J Microbiol Immunol Infect 39 4-10.
440. R Meibalane, GV Sedmak, P Sasidharan, et al. (1977) Outbreak of influenza in a neonatal intensive care unit. J Pediatr 91 974-976.
441. R Kapila, DI Lintz, FT Tecson, et al. (1977) A nosocomial outbreak of influenza A. Chest 71 576-579.
442. ES Balkovic, RA Goodman, FB Rose and CO Borel (1980) Nosocomial influenza A (H1N1) infection. Am J Med Tech 46 318-320.
443. LP Van Voris, RB Belshe and JL Shaffer (1982) Nosocomial influenza B virus infection in the elderly. Ann Intern Med 96 153-158.
444. M Rivera and N Gonzalez (1982) An influenza outbreak in a hospital. Am J Nurs 82 1836-1838.
445. B Bean, FS Rhame, RS Hughes, et al. (1983) Influenza B: hospital activity during a community outbreak. Diagn Microbiol Infect Dis 1 177-183.
446. GW Hammond and M Cheang (1984) Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J 131 449-452.
447. S Weingarten, M Friedlander, D Rascon, et al. (1988) Influenza surveillance in an acute-care hospital. Arch Intern Med 148 113-116.
448. Suspected nosocomial influenza cases in an intensive care unit. MMWR 37 3-4. 9
449. CT Pachucki, SAW Pappas, GF Fuller, et al. (1989) Influenza A among hospital personnel and patients. Ann Intern Med 149 77-80.
450. JT Grayston, VK Diwan, M Cooney and S-P Wang (1989) Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med 149 169-173.
451. JR Serwint and RM Miller (1993) Why diagnose influenza infections in hospitalized pediatric patients? Pediatr Infect Dis J 12 200-204.
452. E Whimbey, LS Elting, RB Couch, et al. (1994) Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 13 437-440.
453. RJ Everts, HJC Hanger, LC Jennings, et al. (1996) Outbreaks of influenza A among elderly hospital inpatients. N Z Med J 109 272-274.
454. S Scheputiuk, K Papanaoum and M Quao (1998) Spread of influenza A virus infection in hospitalized patients with cancer. Aust N Z J Med 28 475-476.
455. FM Munoz, JR Campbell, RL Atman, et al. (1999) Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 18 811-815.
456. RJ Cunney, A Bialachowski, D Thornley, et al. (2000) An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 21 449-454.
457. DM Weinstock, J Eagan, SA Malak, et al. (2000) Control of influenza on a bone marrow transplant unit. Infect Control Hosp Epidemiol 21 730-732.
458. G Barlow and D Nathwani (2000) Nosocomial influenza infection. Lancet 355 1187.
459. S Malavaud, B Malavaud, K Sanders, et al. (2001) Nosocomial influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation 72 535-537.
460. X Sagrera, G Ginovart, F Raspall, et al. (2002) Outbreaks of influenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J 21 196-200.
461. JP Horcajada, T Pumarola, JA Martinez, et al. (2003) A nosocomial outbreak of influenza during a period without influenza activity. Eur Respir J 21 303-307.
462. Y Yonezawa, Y Inoue, Y Kitahori and M Nakano (2006) An influenza AH3 outbreak in a hospital, Nara Prefecture, Japan, in Summer 2005. Jpn J Infect Dis 59 62-63.
463. MR Odelin, B Pozzetto, M Aymard, et al. (1993) Role of influenza vaccination in the elderly during an epidemic of A/H1NI virus in 1988–1989: clinical and serological data. Gerontology 39 109-116.
464. C Serie, M Barme, C Hannoun, et al. (1977) Effects of vaccination on an influenza epidemic in a geriatric hospital. Dev Biol Stand 39 317-321.
465. WN Hall, RA Goodman, GR Noble, et al. (1981) An outbreak of influenza B in an elderly population. J Infect Dis 144 297-302.
466. RA Goodman, WA Orenstein, TF Munro, et al. (1982) Impact of influenza A in a nursing home. JAMA 247 1451-1453.
467. JC Arroyo, B Postic, A Brown, et al. (1984) Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. Am J Infect Control 12 329-334.
468. RW Christie and LL Marquis (1985) Immunization roulette: influenza occurrence in five nursing homes. Am J Infect Control 13 174-177.
469. JT Horman, HC Stetler, E Israel, et al. (1986) An outbreak of influenza A in a nursing home. Am J Public Health 76 501-504.
470. PA Patriarca, JA Weber, RA Parker, et al. (1986) Risk factors for outbreaks of influenza in nursing homes. Am J Epidemiol 124 114-119.
471. MA Strassburg, S Greenland, FJ Sorvillo, et al. (1986) Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 4 38-44.
472. NH Arden, PA Patriarca, MB Fasano, et al. (1988) The role of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 148 865-868.
473. PA Gross, M Rodstein, JR LaMontage, et al. (1988) Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. Arch Intern Med 148 559-561.
474. EE Mast, MW Harmon, S Gravenstein, et al. (1991) Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 134 988-997.
475. Control of influenza A outbreaks in nursing homes amantadine as an adjunct to vaccine-Washington, 1989–90. MMWR Morb Mortal Wkly Rep 40 842-845.
476. Outbreak of influenza A in a nursing home-New York, December 1991-January 1992. MMWR Morb Mortal Wkly Rep 41 129-131.
477. J Degelau, SK Somani, SL Cooper, et al. (1992) Amantadine-resistant influenza A in a nursing facility. Arch Intern Med 152 390-392.
478. JL Taylor, DM Dwyer, T Coffman, et al. (1992) Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definition. Infect Control Hosp Epidemiol 13 93-97.
479. DM Morens and VM Rash (1995) Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol 16 275-280.
480. S Issacs, C Dickenson and G Brimmer (1997) Outbreak of influenza A in an Ontario nursing home-January 1997. Can Commun Dis Rep 23 105-108.
481. SK Bowles, N Kennie, L Ruston, et al. (1999) Influenza outbreak in a long-term care facility: considerations for pharmacy. Am J Health Syst Pharm 56 2303-2307.
482. WL Atkinson, NH Arden, PA Patriarca, et al. (1986) Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 146 1751-1756.
483. C Lee, M Loeb, A Phillips, et al. (2000) Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol 21 700-704.
484. SK Bowles, W Lee, AE Simor, et al. (2002) Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. JAGS 50 608-616.
485. N Shijubo, G Yamada, M Takahashi, T Tokunoh, T Suzuki and S Abe (2002) Experience with oseltamivir in the control of nursing home influenza A outbreak. Intern Med 41 366-370.
486. PJ Drinka, P Krause, L Nest, S Gravenstein, B Goodman and P Shult (2002) Delays in the application of outbreak control prophylaxis for influenza A in a nursing home. Infect Control Hosp Epidemiol 23 600-603.
487. AS Monto, J Rotthoff, E Teich, et al. (2004) Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 39 459-464.
488. M Schilling, S Gravenstein, P Drinka, et al. (2004) Emergence and transmission of amantadine-resistant influenza A in a nursing home. J Am Geriatr Soc 52 2069-2073.
489. KA Bush, J McAnulty, K McPhie, et al. (2004) Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell 28 396-400.
490. van der Sande MAB, Ruijs WLM, Meijer A, Cools HJM, van der Plas SM. Use of oseltamivir in Dutch nursing homes during the 2004–2005 influenza season. Vaccine (In press).
491. J Potter, DJ Stott, MA Roberts, et al. (1997) Influenza vaccination of healthcare workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 175 1-6.
492. WF Carman, AG Elder, LA Wallace, et al. (2000) Effects of influenza vaccination on health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet 355 93-97.
493. WL Atkinson, NH Arden, PA Patriarca, et al. (1986) Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 146 1751-1756.
494. ME Evans, KL Hall and SE Berry (1997) Influenza control in acute care hospitals. Am J Infect Control 25 357-362.
495. OC Tablon, LJ Anderson, R Besser, C Bridges and R Hajjeh (2004) Guidelines for preventing health-care-associated pneumonia, 2003. MMWR 53(RR-3), 1-36.
496. DB Bridges, MJ Kuehnert and CB Hall (2003) Transmission of influenza: implications for control in health care settings. Clin Infec Dis 37 1094-1101.
497. MM Zadeh, BC Buxton, WW Thompson, NH Arden and K Fukuda (2000) Influenza outbreak detection and control measures in nursing homes in the United States. J Am Geriatr Soc 48 1310-1315.
498. SF Bradley (1999) Prevention of influenza in long-term-care facilities. Infect Control Hosp Epidemiol 20 629-637.
499. NH Arden (2000) Control of influenza in the long-term-care facility: a review of established approaches and newer options. Infect Control Hosp Epidemiol 21 59-64.
500. IH Gomolin and RK Kathpalia (2002) Influenza. How to prevent and control nursing home outbreaks. Geriatr 57 28-30. 33–34
501. GP Dash, L Faurerback, J Pfeiffer, et al. (2004) APIC position paper: improving health care worker influenza immunization rates. Am J Infect Control 32 123-125.
502. KL Nichol, A Lind, KL Margolis, et al. (1995) The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 333 889-893.
503. ML Russell and EA Henderson (2003) The measurement of influenza vaccine coverage among health care workers. Am J Infect Control 31 457-461.
504. RA Martinello, L Jones and JE Topal (2003) Correlation between healthcare workers’ knowledge of influenza vaccine and vaccine receipt. Infect Control Hosp Epidemiol 24 845-847.
505. RT Lester, A McGeer, G Tomlinson and AS Detsky (2003) Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff. Infect Control Hosp Epidemiol 24 839-844.
506. G Bearman, L Fuentes, JVL Vorenkamp and LM Drusin (2003) Vaccination without documentation: influenza immunizations among medical residents at a tertiary-care medical center. Infect Control Hosp Epidemiol 24 626-628.
507. MW Mah, NA Hagen, K Pauling-Shepard, et al. (2005) Understanding influenza vaccination attitudes at a Canadian cancer center. Am J Infect Control 33 243-250.
508. HS Canning, J Phillips and S Allsup (2005) Health care worker beliefs about influenza vaccine and reasons for non-vaccination—a cross-sectional survey. J Clin Nursing 14 922-925.
509. T Tapiainen, G Bar, UB Schaad and U Heininger (2005) Influenza vaccination among healthcare workers in a university children's hospital. Infect Control Hosp Epidemiol 26 855-858.
510. Wodi AP, Samy S, Ezeanolue E, et al. Influenza vaccine: immunization rates, knowledge, and attitudes of resident physicians in an urban teaching hospital. Infect Control Hosp Epidemiol 26:867–873.
511. D Bautista, B Vila, R Uso, M Tellez and V Zanon (2006) Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers. Infect Control Hosp Epidemiol 27 73-77.
512. AE Cowan, CA Winston, MM Davis, PM Whorley and SJ Clark (2006) Influenza vaccination status and influenza-related perspectives and practices among US physicians. Am J Infect Control 34 164-169.
513. C Sartor, H Tissot-Dupont, C Zandotti, F Martin, P Roques and M Drancourt (2004) Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 25 918-922.
514. SE Cosgrove, NO Fishman, TR Talbot, et al. (2005) Strategies for use of a limited influenza vaccine Supply. JAMA 293 229-232.
515. Pertussis vaccination use of acellular pertussis vaccines among infants and young children. MMWR 46(RR-7), 1-25.
516. JD Cherry (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatr 115 1422-1427.
517. CHW von Konig, S Halperin, M Riffelmann and N Guiso (2002) Pertussis of adults and infants. Lancet Infect Dis 2 744-750.
518. JD Cherry, E Grimprel, N Guiso, U Heininger and J Mertsola (2005) Defining pertussis epidemiology. Clinical, microbiolgic and serologic perspective. Pediatr Infect Dis J 24 S25-S34.
519. JD Cherry (2006) Epidemiology of pertussis. Pediatr Infect Dis J 25 361-362.
520. E Galanis, A King, P Varughese and SA Halperin (2006) Changing epidemiology and emerging risk groups for pertussis. CMAJ 174 451-452.
521. K Edwards and DM Freeman (2006) Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr 18 77-80.
522. NS Crowcroft and RG Pebody (2006) Recent developments in pertussis. Lancet 367 1926-1936.
523. JG Deville, JD Cherry, PD Christenson, et al. (1995) Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 21 639-642.
524. TL Kurt, AS Yeager, S Guenette and S Dunlop (1972) Spread of pertussis by hospital staff. JAMA 221 264-267.
525. CC Linnemann, N Ramundo, PH Perlstein, et al. (1975) Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 2 540-543.
526. WM Valenti, PH Pincus and MK Messner (1980) Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 134 520-521.
527. RW Steketee, SGF Wassilak, WN Adkins, et al. (1988) Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 157 434-440.
528. MC Fisher, SS Long, KL McGowan, et al. (1989) Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 114 934-939.
529. DG Addiss, JP Davis, BD Meade, et al. (1991) A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 164 704-710.
530. Y Tanaka, K Fujinaga, A Goto, et al. (1991) Outbreak of pertussis in a residential facility for handicapped people. Dev Biol Stand 73 329-332.
531. A Shefer, L Dales, M Nelson, et al. (1995) Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 171 1053-1056.
532. CDC Christie, AM Glover, MJ Willke, et al. (1995) Containment of pertussis in the regional pediatric hospital during the greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 16 556-563.
533. SM Martinez, CA Kemper, D Haiduven, SH Cody and SC Deresinski (2001) Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness. Infect Control Hosp Epidemiol 22 781-783.
534. NM Spearing, RL Horvath and JG McCormick (2002) Pertussis: adults as a source in healthcare settings. MJA 117 568-569.
535. MJ Ferson, K Morgan, PW Robertson, AW Hampson, I Carter and WD Rawlinson (2004) Concurrent summer influenza and pertussis outbreaks in a nursing home in Sydney, Australia. Infect Control Hosp Epidemiol 25 962-966.
536. L Bassinet, M Matrat, E Njamkepo, S Aberrane, B Housset and N Guiso (2004) Nosocomial pertussis among adult patients and healthcare workers. Infect Control Hosp Epidemiol 25 995-997.
537. A Calugar, IR Ortega-Sanchez, T Tiwari, L Oakes, JA Jahre and TV Murphy (2006) Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 42 981-989.
538. A Ward, J Caro, L Bassinet, B Housset, JA O'Brien and N Guiso (2005) Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol 26 288-292.
539. BR Boulay, CJ Murray, J Ptak, KB Kirkland, J Montero and EA Talbot (2006) An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 27 92-95.
540. KA Bryant, K Humbaugh, K Brothers, et al. (2006) Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect Control Hosp Epidemiol 27 541-545.
541. FB Pascual, CL McCall, A McMurtray, et al. (2006) Outbreak of pertussis among healthcare workers in a hospital surgical unit. Infect Control Hosp Epidemiol 27 546-552.
542. C Guiglinai, G Vidal-Trecan, S Traore, et al. (2006) Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris. Infect Control Hosp Epidemiol 27 626-629.
543. DJ Weber and WA Rutala (1994) Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 15 411-415.
544. DJ Weber and WA Rutala (2001) Pertussis: a continuing hazard for healthcare facilities. Infect Control Hosp Epidemiol 22 736-740.
545. JI Ward, JD Cherry, PJ Chang, et al. (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. New Engl J Med 353 1555-1563.
546. G Zackrisson, J-E Brorson, I Krantz and B Trollfors (1983) In-vitro sensitivity of Bordetella pertussis. J Antimicrob Chemother 11 407-411.
547. T Kurzynski, DM Boehm, JA Rott-Petri, et al. (1988) Antimicrobial susceptibilities of Bordetella species isolated in a multicenter pertussis surveillance project. Antimicrob Agents Chemother 32 137-140.
548. JE Hoppe and A Eichhorn (1989) Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis 8 653-654.
549. ME Appleman, TL Hadfield, JK Gaines and RE Winn (1987) Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs. Diagn Microbiol Infect Dis 8 131-133.
550. JE Hoppe and CG Simon (1990) In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. Antimicrob Agents Chemother 34 2287-2288.
551. JE Hoppe and A Haug (1988) Antimicrobial susceptibility of Bordetella pertussis: Part I. Infection 16 126-130.
552. G Granstrom, G Sterner, CE Nord and M Granstrom (1987) Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J Infect Dis 155 1210-1214.
553. MA Sprauer, SL Cochi, ER Zell, et al. (1992) Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child 146 177-181.
554. G De Serres, N Boulianne and B Duval (1995) Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr Infect Dis J 4 969-975.
555. S Altunaiji, R Kukuruzovic, N Curtis and J Massie (2005) Antibiotics for whooping cough (pertussis). The Cochrane Database of Systematic Reviews
556. Recommended antimicrobial agents for treatment and postexposure prophylaxis of pertussis. MMWR 54(RR-14), 1-15.
557. RL Henry, DC Dorman, JA Skinner and CM Mellis (1981) Antimicrobial therapy in whooping cough. Med J Aust 2 27-28.
558. JE Hoppe, U Halm, H-J Hagedorn and A Kraminer-Hagedorn (1989) Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 17 227-231.
559. K Lewis, MA Saubolle, FC Tenover, et al. (1995) Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 14 388-391.
560. EK Korgenski and JA Daly (1997) Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the intermountain West Region of the United States. J Clin Microbiol 35 2989-2991.
561. JE Hoppe and A Bryskier (1998) In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3652), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin) and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother 42 965-966.
562. M Brett, P Short and S Beatson (1998) The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis. J Antimicrob Chemother 41(Suppl B), 23-27.
563. KA Gordon, J Fusco, DJ Biedenbach, et al. (2001) Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from Northern California: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 45 3599-3600.